Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Clinical trial NCT04272034 · TERMINATED

Trial details

NCT number: NCT04272034
Sponsor: Incyte Corporation
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors MSI-H/dMMR Tumors Cutaneous Squamous Cell Carcinoma Urothelial Carcinoma, HCC Cervical Cancer Esophageal Squamous Cell Carcinoma Merkel Cell Carcinoma Small-cell Lung Cancer Mesothelioma PD-L1 Amplified Tumor (9p24.1)Nasopharyngeal Carcinoma Cyclin-dependent Kinase 12 Mutated Tumors

Start date: 2021-03-26
Primary completion: 2024-08-16
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.